Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: An update review

Kaohsiung Journal of Medical Sciences

Volumn 28, Issue 4, 2012, Pages 185-193

  Yeh, Yi Chun ^a   Ouyang, Wen Chen ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Jianan Mental Hospital   (Taiwan)

^c CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Behavioral and psychological symptoms of dementia (BPSD); Dementia; Mood stabilizers; Review

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; HLA B ANTIGEN; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

AGE; AGGRESSION; AGITATION; ATAXIA; BEHAVIOR DISORDER; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA; COGNITIVE DEFECT; CONFUSION; DEMENTIA; DEPRESSION; DIARRHEA; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INTOXICATION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPILEPSY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HOSTILITY; HUMAN; HYPONATREMIA; INTELLECTUAL IMPAIRMENT; MAXIMUM TOLERATED DOSE; META ANALYSIS (TOPIC); MONOTHERAPY; MOOD DISORDER; NAUSEA; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION; TREMOR; URINARY TRACT INFECTION; VOMITING;

ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; DEMENTIA; HUMANS; TRIAZINES; VALPROIC ACID;

EID: 84859108204     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2011.10.025     Document Type: Review

References (67)

1. R.F. Coen, G.R. Swanwick, C.A. O'Boyle, and D. Coakley Behaviour disturbance and other predictors of carer burden in Alzheimer's disease Int J Geriatr Psychiatry 12 1997 331 336 (Pubitemid 27148454)
2. C. Steele, B. Rovner, G.A. Chase, and M. Folstein Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease Am J Psychiatry 147 1990 1049 1051 (Pubitemid 20257519)
3. D.L. Murman, and C.C. Colenda The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden? Pharmacoeconomics 23 2005 227 242 (Pubitemid 40663630)
4. G.S. Alexopoulos, J. Streim, D. Carpenter, and J.P. Docherty Using antipsychotic agents in older patients J Clin Psychiatry 65 Suppl. 2 2004 5 20
5. C. Ballard, and J. Waite The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease Cochrane Database Syst Rev 2006 1 128
6. US Food and Drug Administration. Antipsychotics, conventional and atypical. US Food and Drug Administration (FDA) www.fda.gov. www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm110212.htm. [Accessed 10.02.10].
7. US Food and Drug Administration. Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. US Food and Drug Administration (FDA) www.fda.gov. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171. htm. [Accessed 11.07.10].
8. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, and D.J. Gavaghan Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
9. R.B. Haynes, D.L. Sackett, G.H. Guyatt, and P. Tugwell Clinical epidemiology: how to do clinical practice research 3rd ed. 2006 Lippincott Williams & Wilkins New York, NY
10. S.A. Olivo, L.G. Macedo, I.C. Gadotti, J. Fuentes, T. Stanton, and D.J. Magee Scales to assess the quality of randomized controlled trials: a systematic review Phys Ther 88 2008 156 175 (Pubitemid 351210558)
11. L.V. Hedges Distribution theory for Glass's estimator of effect size and related estimators J Educ Stat 6 1981 107 128
12. M.H. Ebell, J. Siwek, B.D. Weiss, S.H. Woolf, J. Susman, and B. Ewigman Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature Am Fam Physician 69 2004 548 556 (Pubitemid 38176273)
13. C.G. Ballard, S. Gauthier, J.L. Cummings, H. Brodaty, G.T. Grossberg, and P. Robert Management of agitation and aggression associated with Alzheimer disease Nat Rev Neurol 5 2009 245 255
14. J.T. Olin, L.S. Fox, S. Pawluczyk, N.A. Taggart, and L.S. Schneider A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease Am J Geriatr Psychiatry 9 2001 400 405 (Pubitemid 33015127)
15. P.N. Tariot, R. Erb, C.A. Podgorski, C. Cox, S. Patel, and L. Jakimovich Efficacy and tolerability of carbamazepine for agitation and aggression in dementia Am J Psychiatry 155 1998 54 61 (Pubitemid 28037549)
16. C. Cooney, A.N.N. Mortimer, A. Smith, K. Newton, and M. Wrigley Carbamazepine use in aggressive behavior associated with senile dementia Int J Geriatr Psychiatry 11 1996 901 905 (Pubitemid 26358777)
17. C.A. Chambers, J. Bain, R. Roshottom, B.R. Ballinger, and S. McLaren Carbamazepine in senile dementia and overactivity: a placebo, controlled double-blind trial IRCS Med Sci 10 1982 505 506 (Pubitemid 12122423)
18. US Food and Drug Administration. Information for healthcare professionals: Dangerous or even fatal skin reactions - carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics). US Food and Drug Administration www.fda.gov. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm124718.htm. [Accessed 01.03.11].
19. A.M. Mellow, C. Solano-Lopez, and S. Davis Sodium valproate in the treatment of behavioral disturbance in dementia J Geriatr Psychiatry Neurol 6 1993 205 209 (Pubitemid 23302139)
20. A.D. Lott, S.L. McElroy, and M.A. Keys Valproate in the treatment of behavioral agitation in elderly patients with dementia J Neuropsychiatry Clin Neurosci 7 1995 314 319
21. S. Haas, K. Vincent, J. Holt, and S. Lippmann Divalproex: a possible treatment alternative for demented, elderly aggressive patients Ann Clin Psychiatry 9 1997 145 147 (Pubitemid 27470385)
22. M. Narayan, and J.C. Nelson Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic J Clin Psychiatry 58 1997 351 354 (Pubitemid 27375463)
23. N. Herrmann Valproic acid treatment of agitation in dementia Can J Psychiatry 43 1998 69 72 (Pubitemid 28125132)
24. A.P. Porsteinsson, P.N. Tariot, L.J. Jakimovich, N. Kowalski, C. Holt, and R. Erb Valproate therapy for agitation in dementia: open-label extension of a double-blind trial Am J Geriatr Psychiatry 11 2003 434 440 (Pubitemid 36807639)
25. R.C. Sival, H.J. Duivenvoorden, P.A. Jansen, P.M. Haffmans, S.A. Duursma, and P. Eikelenboom Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study Int J Geriatr Psychiatry 19 2004 305 312 (Pubitemid 38461068)
26. B. Forester, M. Vanelli, J. Hyde, R. Perez, C. Ahokpossi, and W. Sribney Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication Am J Geriatr Pharmacother 5 2007 209 217 (Pubitemid 350063664)
27. N. Herrmann, K.L. Lanctot, L.S. Rothenburg, and G. Eryavec A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease Dement Geriatr Cogn Disord 23 2007 116 119 (Pubitemid 46105702)
28. A.P. Porsteinsson, P.N. Tariot, R. Erb, C. Cox, E. Smith, and L. Jakimovich Placebo-controlled study of divalproex sodium for agitation in dementia Am J Geriatr Psychiatry 9 2001 58 66 (Pubitemid 32062073)
29. P.N. Tariot, L.S. Schneider, J.E. Mintzer, A.J. Cutler, M.R. Cunningham, and J.W. Thomas Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial Current Therapeutic Research 62 2001 51 67 (Pubitemid 32493031)
30. R.C. Sival, P.M. Haffmans, P.A. Jansen, S.A. Duursma, and P. Eikelenboom Sodium valproate in the treatment of aggressive behavior in patients with dementia - a randomized placebo controlled clinical trial Int J Geriatr Psychiatry 17 2002 579 585 (Pubitemid 34678711)
31. P.N. Tariot, R. Raman, L. Jakimovich, L. Schneider, A. Porsteinsson, and R. Thomas Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial Am J Geriatr Psychiatry 13 2005 942 949 (Pubitemid 46638660)
32. E. Lonergan, and J. Luxenberg Valproate preparations for agitation in dementia Cochrane Database Syst Rev 2009 1 45
33. A.P. Porsteinsson Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly Drugs Aging 23 2006 877 886 (Pubitemid 44788140)
34. N. Herrmann, K. Lanctot, and M. Myszak Effectiveness of gabapentin for the treatment of behavioral disorders in dementia J Clin Psychopharmacol 20 2000 90 93 (Pubitemid 30056359)
35. C. Dallocchio, C. Buffa, and P. Mazzarello Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease J Clin Psychiatry 61 2000 64 (Pubitemid 30104390)
36. F. Raudino, M.G. Mascalzi, and A. Zagami Gabapentin and behavioral disorders in severe Alzheimer disease J Clin Psychopharmacol 24 2004 459 460 (Pubitemid 38944152)
37. R. Moretti, P. Torre, R.M. Antonello, and G. Cazzato Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients Eur J Neurol 8 2001 501 502 (Pubitemid 34203446)
38. R. Moretti, P. Torre, R.M. Antonello, G. Cazzato, and A. Bava Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation Drugs Aging 20 2003 1035 1040 (Pubitemid 37549878)
39. W.M. Regan, and S.M. Gordon Gabapentin for behavioral agitation in Alzheimer's disease J Clin Psychopharmacol 17 1997 59 60 (Pubitemid 27047268)
40. G. Goldenberg, K. Kahaner, N. Basavaraju, and S. Rangu Gabapentin for disruptive behaviour in an elderly demented patient Drugs Aging 13 1998 183 184 (Pubitemid 28420001)
41. L.J. Sheldon, R.J. Ancill, and S.G. Holliday Gabapentin in geriatric psychiatry patients Can J Psychiatry 43 1998 422 423
42. R.A.J. Low, and M. Brandes Gabapentin for the management of agitation J Clin Psychopharmacol 19 1999 482 483
43. L.J. Miller Gabapentin for treatment of behavioral and psychological symptoms of dementia Ann Pharmacother 35 2001 427 431 (Pubitemid 32260208)
44. C. Alkhalil, N. Hahar, B. Alkhalil, G. Zavros, and D.T. Lowenthal Can gabapentin be a safe alternative to hormonal therapy in the treatment of inappropriate sexual behavior in demented patients? Int Urol Nephrol 35 2003 299 302 (Pubitemid 38418234)
45. D.M. Roane, T.E. Feinberg, L. Meckler, C.R. Miner, A. Scicutella, and R.N. Rosenthal Treatment of dementia-associated agitation with gabapentin J Neuropsychiatry Clin Neurosci 12 2000 40 43 (Pubitemid 30093687)
46. A. Mowla, and A. Pani Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial J Clin Psychopharmacol 30 2010 40 43
47. B. Fhager, I.M. Meiri, M. Sjogren, and A. Edman Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study Int Psychogeriatr 15 2003 307 309 (Pubitemid 38021262)
48. A.P. Aldenkamp Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults Neurology 54 2000 271 272
49. A.P. Aldenkamp, G. Baker, O.G. Mulder, D. Chadwick, P. Cooper, and J. Doelman A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures Epilepsia 41 2000 1167 1178
50. A.P. Aldenkamp Effects of antiepileptic drugs on cognition Epilepsia 42 Suppl. 1 2001 46 49 (Pubitemid 32453633)
51. A.L. Berkowitz, and M. Semenchuk Effectiveness and tolerability of lamotrigine for acute agitation and aggression in dementia 16th Annual Meeting 2003 American Association for Geriatric Psychiatry Honolulu, Hawaii
52. J.S. Aulakh, J.W. Hawkins, H.S. Athwal, J.I. Sheikh, J. Yesavage, and J.R. Tinklenberg Tolerability and effectiveness of lamotrigine in complex elderly patients J Geriatr Psychiatry Neurol 18 2005 8 11 (Pubitemid 40313185)
53. S. Devarajan, and S.M. Dursun Aggression in dementia with lamotrigine treatment Am J Psychiatry 157 2000 1178
54. O.A. De Leon Treatment of psychotic symptoms with lamotrigine in Alzheimer disease J Clin Psychopharmacol 24 2004 232 233 (Pubitemid 38380851)
55. B. Ng, A. Camacho, W. Bardwell, and D.D. Sewell Lamotrigine for agitation in older patients with dementia Int Psychogeriatr 21 2009 207 208
56. S. Tekin, C. Aykut-Bingol, T. Tanridag, and S. Aktan Antiglutamatergic therapy in Alzheimer's disease - effects of lamotrigine. Short communication J Neural Transm 105 1998 295 303 (Pubitemid 28243237)
57. O.H. Sommer, O. Aga, M. Cvancarova, I.C. Olsen, G. Selbaek, and K. Engedal Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia Dement Geriatr Cogn Disord 27 2009 155 163
58. E. Kutluay, K. McCague, J. D'Souza, and A. Beydoun Safety and tolerability of oxcarbazepine in elderly patients with epilepsy Epilepsy Behav 4 2003 175 180 (Pubitemid 37184590)
59. X. Dong, I.E. Leppik, J. White, and J. Rarick Hyponatremia from oxcarbazepine and carbamazepine Neurology 65 2005 1976 1978 (Pubitemid 43970125)
60. W.W. Havens 2nd, and J. Cole Successful treatment of dementia with lithium J Clin Psychopharmacol 2 1982 71 72 (Pubitemid 13245196)
61. P.M. Randels, L.A. Marco, D.I. Ford, R. Mitchell, M. Scholl, and J. Plesnarski Lithium and lecithin treatment in Alzheimer's disease: a pilot study Hillside J Clin Psychiatry 6 1984 139 147 (Pubitemid 15145728)
62. A. Holton, and K. George The use of lithium in severely demented patients with behavioural disturbance Br J Psychiatry 146 1985 99 100
63. P.V. Rabins, and American Psychiatric Association Practice guideline for the treatment of patients with Alzheimer's disease and other dementia Am J Psychiatry 164 2007 5 56 2nd ed
64. S. Konovalov, S. Muralee, and R.R. Tampi Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review Int Psychogeriatr 20 2008 293 308 (Pubitemid 351230232)
65. D. Pinheiro Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD) Encephale [article in French] 34 2008 409 415
66. D.R. Guay Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability Consult Pharm 22 2007 1004 1034 (Pubitemid 350291261)
67. B. Amann, J. Pantel, H. Grunze, E. Vieta, F. Colom, and A. Gonzalez-Pinto Anticonvulsants in the treatment of aggression in the demented elderly: an update Clin Pract Epidemiol Ment Health 5 2009 14